Companies /Consumer Defensive

Procter & Gamble Company

NYSE: PG Household & Personal Products
$171.79
▼ $1.23 (−0.71%) today
Markets closed · 6:28pm ET

PG Coverage Page 36

8:13am ET
Companies and Brands

Nestle Adds Peanut Allergy Treatment to Its Portfolio

Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.

Paul Ausick